- Home
- RCKT vs MSGE Comparison
RCKT vs MSGE Comparison
Compare RCKT & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | MSGE |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 2.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | MSGE |
|---|---|---|
| Price | $3.48 | $53.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $29.12 | ★ $49.80 |
| AVG Volume (30 Days) | ★ 1.9M | 312.0K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $962,282,000.00 |
| Revenue This Year | N/A | $9.47 |
| Revenue Next Year | N/A | $5.43 |
| P/E Ratio | ★ N/A | $75.03 |
| Revenue Growth | N/A | ★ 0.68 |
| 52 Week Low | $2.19 | $28.29 |
| 52 Week High | $13.35 | $55.75 |
Technical Indicators
Market Signals| Indicator | RCKT | MSGE |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 62.60 |
| Support Level | $3.19 | $51.36 |
| Resistance Level | $3.60 | $54.70 |
| Average True Range (ATR) | 0.19 | 1.25 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 59.78 | 55.35 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.